Aggregatibacter Actinomycetemcomitans Leukotoxin (LtxA; Leukothera) Induces Cofilin Dephosphorylation and Actin Depolymerization During Killing of Malignant Monocytes
Overview
Authors
Affiliations
Leukotoxin (LtxA; Leukothera), a protein toxin secreted by the oral bacterium Aggregatibacter actinomycetemcomitans, specifically kills white blood cells (WBCs). LtxA binds to the receptor known as lymphocyte function associated antigen-1 (LFA-1), a β2 integrin expressed only on the surface of WBCs. LtxA is being studied as a virulence factor that helps A. actinomycetemcomitans evade host defences and as a potential therapeutic agent for the treatment of WBC diseases. LtxA-mediated cell death in monocytes involves both caspases and lysosomes; however, the signalling proteins that regulate and mediate cell death remain largely unknown. We used a 2D-gel proteomics approach to analyse the global protein expression changes that occur in response to LtxA. This approach identified the protein cofilin, which underwent dephosphorylation upon LtxA treatment. Cofilin is a ubiquitous actin-binding protein known to regulate actin dynamics and is regulated by LIM kinase (LIMK)-mediated phosphorylation. LtxA-mediated cofilin dephosphorylation was dependent on LFA-1 and cofilin dephosphorylation did not occur when LFA-1 bound to its natural ligand, ICAM-1. Treatment of cells with an inhibitor of LIMK (LIMKi) also led to cofilin dephosphorylation and enhanced killing by LtxA. This enhanced sensitivity to LtxA coincided with an increase in lysosomal disruption, and an increase in LFA-1 surface expression and clustering. Both LIMKi and LtxA treatment also induced actin depolymerization, which could play a role in trafficking and surface distribution of LFA-1. We propose a model in which LtxA-mediated cofilin dephosphorylation leads to actin depolymerization, LFA-1 overexpression/clustering, and enhanced lysosomal-mediated cell death.
Oral Microbiome: A Review of Its Impact on Oral and Systemic Health.
Rajasekaran J, Krishnamurthy H, Bosco J, Jayaraman V, Krishna K, Wang T Microorganisms. 2024; 12(9).
PMID: 39338471 PMC: 11434369. DOI: 10.3390/microorganisms12091797.
Okano T, Ashida H, Komatsu N, Tsukasaki M, Iida T, Iwasawa M Int J Oral Sci. 2024; 16(1):54.
PMID: 39143049 PMC: 11324795. DOI: 10.1038/s41368-024-00315-x.
: From the Oral Cavity to the Heart Valves.
Talapko J, Juzbasic M, Mestrovic T, Matijevic T, Mesaric D, Katalinic D Microorganisms. 2024; 12(7).
PMID: 39065217 PMC: 11279289. DOI: 10.3390/microorganisms12071451.
Therapeutic Applications of Leukotoxin.
Kachlany S, Vega B Pathogens. 2024; 13(5).
PMID: 38787206 PMC: 11123898. DOI: 10.3390/pathogens13050354.
Prince D, Patel D, Kachlany S Sci Rep. 2021; 11(1):18086.
PMID: 34508147 PMC: 8433231. DOI: 10.1038/s41598-021-97545-4.